Chris Samler
Non-Executive Chairman

Appointed to the Chair of Induction Healthcare in June 2022, Christopher has experience as Chief Executive Officer (CEO) and Chair of quoted companies, (both Main Market and AIM), and private businesses in the education, healthcare, services and technology sectors. He has significant experience supporting growth for businesses across the U.S., Europe, Asia, Latin America and the Middle East.

Christopher started his career in the British Army before joining The Boston Consulting Group as an analyst, leading to a variety of senior management positions at Baxter International, the US-based healthcare multinational. Christopher was CEO of several fast-growing venture capital backed healthcare businesses including Imutran Ltd, and Weston Medical plc, which he took through three venture capital funding rounds to an IPO on the Main Market of the London Stock Exchange in 2000.

In 2004, Christopher co-founded Iceni Capital LLP, a private equity / venture capital firm focused on providing capital and operational support to fast growing UK companies in the services sector. He has Chaired a number of high growth technology, healthcare and service companies including TQ Education & Training which was sold to Pearson plc, AirPortr, Sphonic Solutions (recently sold to Signicat AS), Bubble and Tristel plc.

Christopher holds an MA (hons) from the University of Oxford and an MBA from the Harvard Business School.

James Balmain
Chief Executive Officer

An accomplished technology entrepreneur and former corporate executive at the Very Group (Littlewoods, Shop Direct) and EE (Orange and T-Mobile), James now drives growth and sets the overall direction across all facets of Induction’s operations.

Prior to joining the INHC Board in June 2020, James co-founded and led Zesty as CEO for 8 years through multiple investment rounds from leading European & US Venture Capital funds into an award-winning UK Digital Health company.

James has 25+ years of experience building technology companies balanced with a 10 year track record of commercial success selling to NHS hospitals, regional integrated care systems and international healthcare companies.

Guy Mitchell
Chief Financial Officer

Guy Mitchell is a finance professional with over 20 years’ experience in senior financial leadership roles. He has spent the last 10 years specialising in high growth, Private Equity and Venture Capital backed software/technology companies, typically businesses with SaaS models and with a global reach and customer base. Previously Mr Mitchell served as Interim CFO at AIM listed, FreeAgent PLC, a SaaS based accounting software company and as Interim CFO at Oxehealth Limited, a Venture Capital and Private Equity backed global SaaS model medical software supplying mental health trusts and care homes with a niche solution unrivalled in the market. Mr Mitchell was also Finance Director of GFI Max Limited through a significant growth period of £5m to £75m annual recurring revenue in just over three years.

Mr Mitchell’s strengths lie in international financial leadership and management, tax strategy and compliance and business partnering to deliver shareholder value. Throughout his career, Mr Mitchell has overseen the acquisition and integration of five companies from different global locations including the UK, Armenia, the Netherlands and the US, raised over £10m of Venture Capital and Private Equity investment, and grown a finance team of three to 17 in under three years across different geographical locations.

Mr Mitchell is a Qualified Accountant and Chartered Tax Adviser and holds a Mathematical Sciences degree from Edinburgh Napier University

Hugo Stephenson
Non-Executive Director

Hugo has founded several healthcare and biotech services businesses including DrugDev (acquired by IQVIA) MediGuard (owned by IQVIA), Health Research Solutions (acquired by Quintiles, now IQVIA), and MedSeed (acquired by eHealthcare Asia).

Hugo served as full-time Executive Chairman, Product Lead and co-founder at DrugDev from 2012-2017. Previously, Hugo served as Vice President at Quintiles (now IQVIA) from 2002 to 2011.

Andy Williams
Non-Executive Director

In addition to his role at Induction, Andy is chairman of Docly AB and a non-executive director at Logex Group. His most recent full time role was CEO of NHS Digital, the government body responsible for technology and data for the NHS.

Prior to that, his career was in the technology industry, holding a wide variety of senior roles in IBM, Alcatel-Lucent and CSC. He holds an MA in mathematics and engineering from Cambridge University.

Jane Silber
Non-Executive Director

Jane is Executive Chair of Diffblue Ltd and a non-executive director of The Sensible Code Company Limited. She also serves as an advisor for tech start-ups.

Previously she was CEO of Canonical for 7 years, which followed a 7 year period as COO of Canonical. With experience in the US, Japan and the UK, she has spent her entire career in software engineering and IT management, starting as a software developer and rising through various leadership roles. She holds a BS from Haverford College, an MS from Vanderbilt University, and an MBA from Oxford University.

Leslie-Ann Reed
Non-Executive Director

Leslie-Ann is a chartered accountant with a diverse background and extensive international experience, having served in both executive and non-executive roles in publicly listed media and professional services companies.

Leslie-Ann is currently Non-Executive Director and Chair of the Audit Committee for Learning Technologies Group plc and Non-Executive Director at Bloomsbury Publishing plc, where she is a member of the Audit and Remuneration Committees. Previously, Leslie-Ann was a Non-Executive Director of the German listed company ZEAL Networks SE where she was Vice Chair of the Supervisory Board and Chaired the Audit Committee. Until May 2018 she was a Non-Executive Director and Chair of the Audit Committee of the London listed publisher Quarto Group, Inc.

From 2010 to 2012 she was Chief Financial Officer of Go Industry Dove Bid plc, leading its successful sale in 2012. Between 2007 and 2010 Leslie-Ann was an adviser to Marwyn Investment Management. Prior to that, she served as Chief Financial Officer of Metal Bulletin plc. Leslie-Ann also held senior finance leadership roles at Universal Pictures, Polygram Music, EMI Music and Warner Communications Inc.